Quality control plan 'to improve all aspects of NHS': Research and development worth pounds 440m will subject the service to 'rigorous analyses'

A MULTI-MILLION pound planning programme for the NHS, designed to introduce quality control into every aspect of the service, from the most effective management techniques to the best surgical laser, is to be launched in June.

By 1997, the programme of research and development will account for 1.5 per cent of the annual NHS budget - pounds 440m a year at current prices.

Next month, the Department of Health will invite applications for a new university-based NHS research unit, which will be multi-disciplinary and have a budget of pounds 1.5m a year, as part of the broader research and development programme.

This silent NHS revolution will put in place rigorous analyses of new and existing concepts and technologies - the research and development approach that industry has taken for more than 30 years. It will shift progress within the NHS from today's science-based and usually piecemeal adoption of new methods to a planned development of the details of the service.

The guidelines to doctors and managers that will follow the R and D initiatives, will have, as key considerations, cost-effectiveness and benefits to patients. Inevitably there will be criticism of the plans on grounds that they will limit professional freedom and eventually outlaw procedures that can be offered on the NHS.

However, Professor Michael Peckham, a cancer specialist and academic who was appointed the first NHS Director of Research and Development in 1991, said that it would be hard for clinicians to resist guidelines about the best way forward, if 'we have developed appropriate research information, and explained this properly'. He went on: 'Differences in clinical practice that matter, will not be justifiable if there is valid data on the problem. I am absolutely convinced that this approach will liberate clinicians.'

Professor Peckham has spent the past two years planning the research and development programme. Much of the new programme will be to harness existing research and to commission new projects. Huge gaps in knowledge about how the system really works and even of what patients want from it, have become apparent.

'Very little research has been done on the health service. We have to create a sound knowledge base and to correct anomalies that exist,' he said.

Examples of discrepancies include unexplained differences in referral patterns by family doctors. It has been found that the further away patients live from their regional liver disease centre, specially funded to provide a region-wide service, the less likely they are to be referred.

'We just don't know why this happens,' he said.

Another example is how consultants differ in putting cataract patients on waiting lists for surgery. 'Some consultants do not put patients on the list until the cataract has advanced, others put patients on the lists sooner. You would suppose that the patients put on later would be treated with more urgency. This seems not too happen.'

Hundreds of millions of pounds are spent on research each year by drugs companies, charities and the research councils, but there is no structure for assessing the results and making the best use of them.

He has estimated that pounds 800m is spent by the pharmaceutical industry annually on research, about a quarter of this is spent in NHS hospitals and medical schools. At the same time the NHS spends about pounds 700m a year on equipment.

Professor Peckham's department will also forge links between different research agencies.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
Have you tried new the Independent Digital Edition apps?
ebooks
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Marketing Manager (B2B) - Romford - £40,000 + car

£35000 - £40000 per annum + car and benefits: Ashdown Group: Marketing Manager...

Ashdown Group: Helpdesk Analyst - Devon - £20,000

£18000 - £20000 per annum: Ashdown Group: Helpdesk Analyst - Devon - £20,000 ...

Ashdown Group: Data Scientist - London - £50,000 + bonus

£35000 - £50000 per annum + generous bonus: Ashdown Group: Business Analytics ...

Ashdown Group: IT Project Coordinator (Software Development) - Kingston

£45000 - £50000 per annum: Ashdown Group: IT Project Coordinator (Software Dev...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'